#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15168	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2167	695.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1454	1454	C	852	C,T	814,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3490	774.8	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	856	C,A,T	808,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3490	774.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1973	1973	G	946	G	897	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3490	774.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	870	C,T	819,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3490	774.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	852	A	812	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3490	774.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	821	C,A	774,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2236	folP	852	852	99.77	folP.l15.c4.ctg.1	1516	146.4	0	.	p	.	0	S68P	NONSYN	202	204	TCG	506	508	CCG	213;215;215	C;C;G	200;199;202	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2236	folP	852	852	99.77	folP.l15.c4.ctg.1	1516	146.4	0	.	p	.	0	A204V	NONSYN	610	612	GCA	914	916	GTA	208;209;211	G;T;A	197;197;195	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2236	folP	852	852	99.77	folP.l15.c4.ctg.1	1516	146.4	1	SNP	p	R228S	1	.	.	682	684	AGC	986	988	AGC	218;219;218	A;G;C	209;210;209	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	174.5	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	182;184;189	T;T;C	173;175;177	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	174.5	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	184;185;186	G,A;G;C	177,1;179;179	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	174.5	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	184;185;186	G,A;G;C	177,1;179;179	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1798	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1436	124.4	1	SNP	p	G45D	0	.	.	133	135	GGC	538	540	GGC	209;212;217	G;G;C	198;197;202	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	916	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1155	79.2	0	.	n	.	0	A197.	DEL	197	197	A	617	617	A	203	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3019	173.2	1	SNP	p	D86N	0	.	.	256	258	GAC	658	660	GAC	203;203;206	G;A;C	185;181;188	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3019	173.2	1	SNP	p	R87W	0	.	.	259	261	CGT	661	663	CGT	208;208;208	C,A;G;T	191,1;189;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3019	173.2	1	SNP	p	R87I	0	.	.	259	261	CGT	661	663	CGT	208;208;208	C,A;G;T	191,1;189;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3019	173.2	1	SNP	p	S87R	1	.	.	259	261	CGT	661	663	CGT	208;208;208	C,A;G;T	191,1;189;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3019	173.2	1	SNP	p	S88P	0	.	.	262	264	TCC	664	666	TCC	212;214;213	T;C;C	192;199;199	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4592	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2683	170.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	256;254;253	G;G;C	241;239;235	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1210	1212	GCC	222;226;227	G;C,G;C	205;203,1;210	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1213	1215	ATG	226;226;225	A;T;G	210;208;206	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1225	1227	ACC	222;224;225	A;C;C	205;209;210	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1225	1227	ACC	222;224;225	A;C;C	205;209;210	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1726	1728	ACC	267;269;268	A;C;C	244;251;252	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1780	1782	GCG	239;238;235	G;C;G	227;221;222	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1780	1782	GCG	239;238;235	G;C;G	227;221;222	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1903	1905	GGT	236;233;232	G;G;T	219;213;211	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1912	1914	AGC	220;219;214	A;G;C	204;202;198	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2338	185.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1930	1932	CCG	169;173;170	C,G;C,G;G	144,5;149,1;144	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5640	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3033	185.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1576	1578	CCG	216;214;213	C;C;G	187;196;187	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2610	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1895	136.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	559	559	C	173	C	165	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	389	24.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	67	69	AAT	12;12;12	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	389	24.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	70	72	AAT	12;12;12	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	389	24.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	94	96	GCA	12;12;12	G;C;A	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	389	24.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	117	119	GTA	9;9;9	G;T;A	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	389	24.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	126	126	A	8	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2904	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1701	169.4	1	SNP	p	G120K	1	.	.	358	360	AAG	700	702	AAG	214;214;213	A;A;G	203;206;203	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2904	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1701	169.4	1	SNP	p	A121N	1	.	.	361	363	AAC	703	705	AAC	213;211;209	A,G;A;C	204,1;201;199	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2904	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1701	169.4	1	SNP	p	N121D	0	.	.	361	363	AAC	703	705	AAC	213;211;209	A,G;A;C	204,1;201;199	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10372	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4824	214.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1192	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	922	127.7	1	SNP	p	V57M	1	.	.	169	171	ATG	470	472	ATG	217;217;216	A;T;G,T	210;208;205,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
